What is 908 Devices?
Headquartered in Boston, 908 Devices is a specialized innovator in the field of chemical analysis. The company designs and manufactures compact, handheld tools that simplify the identification of unknown or hidden substances, providing critical insights at the point of need. By integrating advanced analytical technologies with automated software and machine learning, 908 Devices supports essential health and safety efforts, including the mitigation of hazardous exposure risks, drug crisis management, and global security operations. Its market position is defined by its ability to deliver laboratory-grade precision in portable, field-ready formats, serving a diverse client base that demands reliability and speed in high-stakes environments.
How much funding has 908 Devices raised?
908 Devices has raised a total of $196.8M across 7 funding rounds:
Series A
$8.1M
Series B
$7M
Private Equity
$2.6M
Series C
$11.6M
Private Equity
$20M
Other Financing Round
$17.5M
Stock Offering
$130M
Series A (2012): $8.1M with participation from Razor's Edge Ventures, ARCH Ventures, and In-Q-Tel
Series B (2013): $7M led by SLB, Razor's Edge Ventures, ARCH VENTURE PARTNERS, and The UTEC
Private Equity (2014): $2.6M, investors not publicly disclosed
Series C (2015): $11.6M featuring Saudi Aramco Energy Ventures
Private Equity (2017): $20M backed by Saudi Aramco Energy Ventures, ARCH Venture Partners, Casdin Capital, Razoru2019s Edge Ventures, and Tao Capital Management
Other Financing Round (2019): $17.5M with participation from Saudi Aramco Energy Ventures, Sands Capital Ventures, Razor's Edge Ventures, Tao Capital Management, Casdin Capital, ARCH Ventures, and SLB
Stock Issuance/Offering (2020): $130M led by Undisclosed
Key Investors in 908 Devices
In-Q-Tel
In-Q-Tel is a not-for-profit strategic investment firm that acts as the U.S. national security community's venture arm, identifying and investing in early-stage commercial technology companies to deliver capabilities in biotech, AI, and energy.
ARCH Venture Partners
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often co-founding startups to commercialize innovations from research institutions.
Razor's Edge Ventures
Razor's Edge Ventures specializes in investing at the intersection of national security and commercial enterprise, focusing on rapidly-growing technology companies that provide critical innovation to the sector.
What's next for 908 Devices?
With the support of its recent $130M injection, 908 Devices is well-positioned to accelerate its product roadmap and expand its footprint in both commercial and government sectors. The company's strategic focus will likely center on deepening its machine learning capabilities to enhance the predictive accuracy of its handheld devices. Furthermore, as the organization continues to mature, it is expected to leverage its established partnerships with national security and energy-focused investors to penetrate new vertical markets. The ongoing integration of automated software into its hardware ecosystem remains a key driver for long-term value creation, ensuring that 908 Devices remains a leader in the rapidly evolving landscape of portable analytical instrumentation.
See full 908 Devices company page
